17-31350215-C-T
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP6BS2_Supporting
The NM_001042492.3(NF1):c.7354C>T(p.Arg2452Cys) variant causes a missense change. The variant allele was found at a frequency of 0.0000186 in 1,613,944 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R2452L) has been classified as Uncertain significance.
Frequency
Consequence
NM_001042492.3 missense
Scores
Clinical Significance
Conservation
Publications
- neurofibromatosis type 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, PanelApp Australia, G2P, Genomics England PanelApp
- neurofibromatosis-Noonan syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, PanelApp Australia
- Moyamoya diseaseInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- hereditary pheochromocytoma-paragangliomaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- familial ovarian cancerInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152154Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000159 AC: 4AN: 251362 AF XY: 0.0000147 show subpopulations
GnomAD4 exome AF: 0.00000958 AC: 14AN: 1461672Hom.: 0 Cov.: 31 AF XY: 0.00000825 AC XY: 6AN XY: 727132 show subpopulations
GnomAD4 genome AF: 0.000105 AC: 16AN: 152272Hom.: 0 Cov.: 32 AF XY: 0.000107 AC XY: 8AN XY: 74456 show subpopulations
ClinVar
Submissions by phenotype
not provided Uncertain:2Benign:1
The NF1 c.7354C>T; p.Arg2452Cys variant (rs377662483), also known as c.7291C>T; p.Arg2431Cys for NM_000267.3, is not reported in the medical literature but is reported in ClinVar (Variation ID: 220184). This variant is found in the general population with an overall allele frequency of 0.002% (4/251362 alleles) in the Genome Aggregation Database. The arginine at codon 2452 is highly conserved, and computational analyses (SIFT, PolyPhen-2) predict that this variant is deleterious. However, given the lack of clinical and functional data, the significance of this variant is uncertain at this time. -
- -
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 31882575, 32447321) -
Neurofibromatosis, type 1 Uncertain:1Benign:1
The NF1 c.7354C>T (p.Arg2452Cys) variant was identified at near heterozygous allelic fraction. This variant has been reported in one individual with breast cancer (Jarhelle E et al., PMID: 31882575). This variant has been reported in the ClinVar database as a likely benign germline variant by three submitters and a germline variant of uncertain significance by three submitters (ClinVar ID: 220184), and in one cancer case as a somatic variant in the cancer database COSMIC (COSMIC ID: COSV104420357). Computational predictors are uncertain as to the impact of this variant on NF1 function. The NF1 gene has a low rate of benign missense variation, and pathogenic missense variants are one of the mechanisms of disease. Due to limited information, and based on ACMG/AMP guidelines for variant interpretation (Richards S et al., PMID: 25741868), the clinical significance of this variant is uncertain at this time. -
- -
Neurofibromatosis, type 1;C0349639:Juvenile myelomonocytic leukemia;C0553586:Café-au-lait macules with pulmonary stenosis;C1834235:Neurofibromatosis, familial spinal;C2931482:Neurofibromatosis-Noonan syndrome Uncertain:1
- -
Hereditary cancer-predisposing syndrome Uncertain:1
- -
Hereditary cancer-predisposing syndrome;CN230736:Cardiovascular phenotype Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at